EPISODE · Aug 14, 2026 · 21 MIN
Rewriting the Treatment Playbook for MDS/MPN and Myelofibrosis
from The HemOnc Pulse · host Blood Cancers Today
In this Editor’s Special episode of The HemOnc Pulse, MD Anderson Cancer Center’s Naval Daver, MD, and Naveen Pemmaraju, MD, discuss MDS/MPN overlap conditions and research examining combination therapy with ruxolitinib and azacitidine (AZA), including its potential to improve disease response, symptom control, and outcomes.
Embed this episode
Ready to play
Rewriting the Treatment Playbook for MDS/MPN and Myelofibrosis
0:00
21:41
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The HemOnc Pulse?
This episode is 21 minutes long.
When was this The HemOnc Pulse episode published?
This episode was published on August 14, 2026.
Can I download this The HemOnc Pulse episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!